Bibliografia

Magazyn 2026/1 (10) – Lekarz

37 min
  1. 1 Prof. dr hab. n. med. Krzysztof Kowal, Niewidzialna sieć powiązań. Jak rozpoznać zespół pyłkowo-pokarmowy? (s. 12)
  2. 2 Dr hab. n. med. Natalia Ukleja-Sokołowska, Zespół bylica–seler–przyprawy (s. 16)
  3. 3 Marimer Spray –100% naturalna woda morska (s. 19)
  4. 4 Dr hab. n. med. Kinga Lis, Alergen kontra kuchnia. Dlaczego obróbka kulinarna zmienia oblicze alergenów? (s. 20)
  5. 5 Dr hab. n. med. Emilia Majsiak, Od molekuły do epitopu. Dokąd zmierza diagnostyka alergii? (s. 25)
  6. 6 Dr hab. n. med. Katarzyna Plata-Nazar, Alergia u niemowlaka. Kiedy potrzebne jest mleko na receptę? (s. 27)
  7. 7 Diet. Alicja Wujkowska, Nieoczywiste źródła orzechów w diecie. Na co uważać? (s. 32)
  8. 8 Natalia Gajek, Soczyste, ale groźne. Alergia na brzoskwinie w pigułce (s. 36)
  9. 9 Aleksandra Lipiec, Szlachetna herbata i rzadka alergia. Co kryje się w matchy? (s. 38)
  10. 10 Loratadyna Galena bez laktozy (s. 39)
  11. 11 Prof. dr hab. n. med. Rafał Pawliczak, Terapia złożona w alergicznym nieżycie nosa (s. 40)
  12. 12 Lek. Danuta Ostrowska-Reguła, Odczulanie na brzozę krok po kroku. Ile trwa, jak przebiega i kiedy zacząć? (s. 42)
  13. 13 Prof. dr hab. n. med Maciej Kupczyk, Ebastyna w codziennej praktyce klinicznej (s. 46)
  14. 14 Aleksandra Lipiec, Krajobraz wysokiego ryzyka. Alergia w mieście (s. 48)
  15. 15 Aleksandra Lipiec, Platan w każdym parku? Przed nami pyłkowy armagedon (s. 50)
  16. 16 Agnieszka Kalinowska, Bylica różne ma oblicza (s. 52)
  17. 17 Aleksandra Lipiec, W maju pylą nie tylko trawy. Pyłki szczawiu pod lupą (s. 54)
  18. 18 Sylwia Gałązka, Pyłki roślin. Czy sa się od nich uciec? (s. 56)
  19. 19 Ryaltris. Maksymalna kontrola objawów (s. 57)
  20. 20 Agnieszka Stańczak, Plastik na skórze. Czy poliester uczula? (s. 58)
  21. 21 Agnieszka Stańczak, Pod przykrywką. Alergia na cynk (s. 60)
  22. 22 Barbara Bukowska, Anatomia nadwrażliwości. Co trzeba wiedzieć o uczuleniu na kontrast? (s. 62)
  23. 23 Maria Cabaj, Na styku mikrobiomu i alergii. Rola grzybów Malassezia w AZS (s. 65)
  24. 24 Prof. dr hab. n med. Krzysztof Buczyłko, Gronkowiec i alergia. Duet, który komplikuje leczenie (s. 68)
  25. 25 Dr n. med. Iwona Poziomkowska-Gęsicka, Przyczyna nieznana. Anafilaksja idiopatyczna (s. 70)
  26. 26 Lek. Klaudia Fabijaniak, Kolagen rybi w teorii i praktyce. Od nierealnych obietnic po reakcje niepożądane (s. 78)
  27. 27 Dr hab. n. med. Emilia Majsiak, Spirulina – przeciwalergiczna czy alergizująca? (s. 80)
  28. 28 Diet. Marcelina Bartuzi-Lepczyńska, Mity o alergii pokarmowej u dzieci (s. 82)

Prof. dr hab. n. med. Krzysztof Kowal, Niewidzialna sieć powiązań. Jak rozpoznać zespół pyłkowo-pokarmowy? (s. 12)

[1] Werfel T, Asero R, Ballmer-Weber BK, Beyer K, Enrique E, Knulst AC, Mari A, Muraro A, Ollert M, Poulsen LK, Vieths S, Worm M, Hoffmann-Sommergruber K. Position paper of the EAACI: food allergy due to immunological cross-reactions with common inhalant allergens. Allergy. 2015 Sep;70(9):1079-90. doi: 10.1111/all.12666. Epub 2015 Jul 7. PMID: 26095197.

[2] Wawrzeńczyk, A., & Bartuzi, Z. (2018). Zespoły kliniczne alergii krzyżowej. Alergia Astma Immunologia – przegląd kliniczny, 23(2), 64–66.

[3] Kamath, Sandip D et al. “Cross-reactive epitopes and their role in food allergy.” The Journal of allergy and clinical immunology 151,5 (2023): 1178-1190. doi:10.1016/j.jaci.2022.12.827

[4] Asero, L. Cecchi, V. Pravettoni, E. Scala, and D. Villalta, “ Algorithms in Allergy: Diagnosis and Treatment of Pollen Food Syndrome,” Allergy (2026): 1–4

[5] Haidar L, Bănărescu CF, Uța C, Moldovan SI, Zimbru E-L, Zimbru R-I, Ciurariu E, Georgescu M, Panaitescu C. Pollen–Food Allergy Syndrome: Allergens, Clinical Insights, Diagnostic and Therapeutic Challenges. Applied Sciences. 2025; 15(1):66. https://doi.org/10.3390/app15010066

[6] Dramburg S, Hilger C, Santos AF, et al. EAACI Molecular Allergology User’s Guide 2.0. Pediatr Allergy Immunol. 2023;34 Suppl 28:e13854. doi:10.1111/pai.13854

[7] Giovannini, Mattia et al. “Diagnosis and Management of Pollen Food Allergy Syndrome to Nuts.” The journal of allergy and clinical immunology. In practice 12,3 (2024): 599-604. doi:10.1016/j.jaip.2024.01.025

[8] Scheurer S, van Ree R, Vieths S. The Role of Lipid Transfer Proteins as Food and Pollen Allergens Outside the Mediterranean Area. Curr Allergy Asthma Rep. 2021;21(2):7. Published 2021 Feb 3. doi:10.1007/s11882-020-00982-w

[9] Scheurer, S., van Ree, R. & Vieths, S. The Role of Lipid Transfer Proteins as Food and Pollen Allergens Outside the Mediterranean Area. Curr Allergy Asthma Rep 21, 7 (2021). https://doi.org/10.1007/s11882-020-00982-w

[10] Garino C, Coïsson JD, Arlorio M. In silico allergenicity prediction of several lipid transfer proteins. Computational Biology and Chemistry. 2016;60:32-42. doi:10.1016/j.compbiolchem.2015.11.006

[11] Lupinek C, Forstenlechner P, Ringauf A, Campana R, Salihu A, Aumayr M, Mittermann I. Big Data-Driven Evolution of a Diagnostic Multiplex IgE-Test: Enhancing Accuracy and Efficacy in Allergy Diagnostics. International Journal of Molecular Sciences. 2025; 26(9):4249. https://doi.org/10.3390/ijms26094249

[12] Ballmer-Weber, Barbara K et al. “New light on an old syndrome: Role of Api g 7 in mugwort pollen-related celery allergy.” The Journal of allergy and clinical immunology 154,3 (2024): 679-689.e5. doi:10.1016/j.jaci.2024.04.030

Dr hab. n. med. Natalia Ukleja-Sokołowska, Zespół bylica–seler–przyprawy (s. 16)

[1] Werfel T, Asero R, Ballmer-Weber BK, Beyer K, Enrique E, Knulst AC, et al. Position paper of the EAACI: food allergy due to immunological cross-reactions with common inhalant allergens. Allergy. 2015;70(9):1079–1090.

[2] Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, Valenta R, Hilger C, Hofmaier S, et al. EAACI molecular allergology user’s guide. Pediatr Allergy Immunol. 2016;27(Suppl 23):1–250.

[3] Asero R, Mistrello G, Roncarolo D, Amato S, Zanoni D, Barocci F, et al. Lipid transfer protein: a pan-allergen in plant-derived foods. Int Arch Allergy Immunol. 2000;122(1):20–32.

[4] Valenta R, Duchêne M, Ebner C, Valent P, Sillaber C, Deviller P, et al. Profilins constitute a novel family of functional plant pan-allergens. J Exp Med. 1992;175(2):377–385.

[5] WHO/IUIS Allergen Nomenclature Sub-Committee. Allergen Nomenclature Database. Available from: http://www.allergen.org

[6] Breiteneder H, Ebner C. Molecular and biochemical classification of plant-derived food allergens. J Allergy Clin Immunol. 2000;106(1 Pt 1):27–36.

[7] Ballmer-Weber BK, Hoffmann A, Wüthrich B, Lüttkopf D, Pompei C, Wangorsch A, et al. Celery allergy confirmed by double-blind placebo-controlled food challenge: a clinical study in 32 subjects with specific IgE to celery. J Allergy Clin Immunol. 2000;106(2):373–378.

[8] Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 2011 on the provision of food information to consumers. Off J Eur Union. 2011;L304:18–63.

[9] Burbach GJ, Heinzerling LM, Edenharter G, et al. GA²LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy. 2009;64(10):1507–1515.

[10] Matricardi PM, Dramburg S, Potapova E, Skevaki C, Renz H. Molecular diagnosis for allergen immunotherapy. J Allergy Clin Immunol. 2019;143(3):831–843.

[11] Wüthrich B. Lethal or life-threatening allergic reactions to food. Allergy. 2000;55(Suppl 61):59–66.

[12] Zuidmeer L, Goldhahn K, Rona RJ, et al. The prevalence of plant food allergies: a systematic review. J Allergy Clin Immunol. 2008;121(5):1210–1218.

[13] Himly M, Jahn-Schmid B, Dedic A, et al. Art v 1, the major mugwort pollen allergen. J Allergy Clin Immunol. 2003;111(4):889–896.

[14] Faber MA, Foetisch K, Vieths S, et al. Defensin-related food allergy: insights into the celery–mugwort syndrome. J Allergy Clin Immunol. 2016;138(2):106–108.

[15] Pastorello EA, Farioli L, Pravettoni V, et al. The lipid transfer protein family as food allergens. Clin Exp Allergy. 2008;38(8):1263–1272.

[16] Wangorsch A, Lidholm J, Mattsson LA, Larsson H, Reuter A, Gubesch M, Gadermaier G, Bures P, Scheurer S, Ballmer-Weber B, Vieths S. Identification of a defensin as novel allergen in celery root: Api g 7 as a missing link in the diagnosis of celery allergy? Allergy. 2022 Apr;77(4):1294-1296. doi: 10.1111/all.15196. Epub 2021 Dec 21. PMID: 34908171.

[17] Ortolani C, Ispano M, Pastorello EA, Bigi A, Ansaloni R. The oral allergy syndrome. Ann Allergy. 1988;61(6 Pt 2):47–52.

Marimer Spray –100% naturalna woda morska (s. 19)

[1] Wingrave W.: The nature of discharges and douches. Lancet 1902; 17: 1373-1375.

[2] Kassel J.C., King D., Spurling G.K.: Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev 2010; 3: CD006821

[3] Krajewska J.: Preparaty OTC w pielęgnacji dróg oddechowych. Lek w Polsce 2017; 27 (319): 18-27

[4] Samoliński B., Klasyfikacja nieżytów nosa (2024). Samoliński B., Algorytmy diagnostyki ANN (2024). Samoliński B., Krzych-Fałta E. (red.), Nowoczesna diagnostyka alergicznego nieżytu nosa. Wydawnictwo Naukowe PWN, Warszawa.

Dr hab. n. med. Kinga Lis, Alergen kontra kuchnia. Dlaczego obróbka kulinarna zmienia oblicze alergenów? (s. 20)

[1] Matsuo H, Yokooji T, Taogoshi T. Common food allergens and their IgE-binding epitopes. Allergol Int. 2015,64(4):332-343.

[2] Lisowska E. Białka jako antygeny. Reakcje z przeciwciałami i analiza epitopów. Kosmos. 1992,41(4):309-323.

[3] Wawrzeńczyk A, Napiórkowska-Baran K, Wawrzeńczyk A, Alska E, Bartuzi Z. Panalergeny – źródło alergii pokarmowej. Alergia Astma Immunologia 2019,24(4):164-169.

[4] Panaszek B, Szmagierowski W. Podstawy patomechanizmu zjawiska alergii krzyżowej. Alergia.2010,3:39-46.

[5] Swientoniewski LT i Linear and conformational epitopes of vicilin-buried peptides as a model for improved nut allergy diagnostics. Front Allergy. 2025,6:1648262.

[6] Kamath SD, Bublin M, Kitamura K, Matsui T, Ito K, Lopata AL. Cross-reactive epitopes and their role in food allergy. J Allergy Clin Immunol. 2023,(5):1178-1190.

[7] Ivanciuc O i wsp. Structural analysis of linear and conformational epitopes of allergens. Regul Toxicol Pharmacol. 2009,54(3 Suppl):S11-19.

[8] Dall’antonia F, Pavkov-Keller T, Zangger K, Keller W. Structure of allergens and structure based epitope predictions. Methods. 2014,66(1):3-21.

[9] Aalberse RC, Crameri R. IgE-binding epitopes: a reappraisal. Allergy. 2011,66(10):1261-1274.

[10] Breiteneder H. Mapping of conformational IgE epitopes of food allergens. Allergy.2018,73(11):2107-2109.

[11] Mishra A, Jain A, Arora N. Mapping B-cell epitopes of major and minor peanut allergens and identifying residues contributing to IgE binding. J Sci Food Agric. 2016,96(2):539-547.

[12] Sanchez-Trincado JL, Gomez-Perosanz M, Reche PA. Fundamentals and Methods for T- and B- Cell Epitope Prediction. J Immunol Res. 2017,2017:2680160.

[13] Kulbat K, Leszczyńska J. Roślinne białka obronne jako alergeny. Kosmos. 2015,64(2):271-280.

[14] Trzcińska M. Białka stresu roślinnego źródłem alergenów występujących w owocach i warzywach. Acta Scientiarum Polonorum –Biotechnologia. 2014,13(1):13-20.

[15] Konopka I, Tańska M. Przewodnik do zajęć laboratoryjnych. Żywność jako źródło alergenów. Uniwersytet Warmińsko-Mazurski w Olsztynie. Wydziała Nauki o Żywności. Katedra Przetwórstwa i Chemii Surowców Roślinnych. Olsztyn 2020.

[16] Wojnowicz E i wsp. Określenie możliwych kierunków przetwórstwa żywności w gospodarstwach rolnych wraz z opracowaniem stosownych instrukcji technologicznych i metodyk zapewniających wytworzenie bezpiecznego produktu. Badania zrealizowane w ramach Zadania 3.: Ekspertyzy, opinie wspomagające projektowanie interwencji PS WPR 2023 – 2027 realizowanego na zlecenie Ministerstwa Rolnictwa i Rozwoju Wsi na podstawie umowy nr DRR.prz.070.1.2022. Grudzień 2022.

[17] Ukleja-Sokołowska N: Przetwarzanie żywności a alergia pokarmowa. Alergia.2017,1:23-27.

[18] Makała H. Wpływ procesów technologicznych na zmiany alergenności żywności oraz praktyk przemysłowych zwiększających efektywność zarządzania alergenami wewnątrz firmy. Postępy Nauki i Technologii Przemysłu Rolno-Spożywczego 2017, 72(4):77-91.

[19] Szymkiewicz A, Jędrychowski L, Wagner A. Wpływ obróbki termicznej i hydrolizy enzymatycznej na alergenność białek grochu. Żywność. NAUKA. Technologia. Jakość. 2007,3(52):147-158.

[20] Wróblewska B, Szymkiewicz A, Jędrychowski L. Wpływ procesów technologicznych na zmiany alergenności żywności. ŻYWNOŚĆ. Nauka. Technologia. Jakość.2007,6(55),7-19.

Dr hab. n. med. Emilia Majsiak, Od molekuły do epitopu. Dokąd zmierza diagnostyka alergii? (s. 25)

[1] Gupta, N.,M. Anand Allergy Skin Testing. Journal of Pediatric Pulmonology, 2023. 2(Supp1 2): p. S112-S118.

[2] Platts-Mills, T.A., et al. The discovery of IgE 50 years later. Ann Allergy Asthma Immunol, 2016. 116(3): p. 179-82.

[3] Dodig, S.,I. Čepelak The potential of component-resolved diagnosis in laboratory diagnostics of allergy. Biochem Med (Zagreb), 2018. 28(2): p. 020501.

[4] Alessandri, C., et al. Diagnosing allergic sensitizations in the third millennium: why clinicians should know allergen molecule structures. Clin Transl Allergy, 2017. 7: p. 21.

[5] Lupinek, C., et al. Big Data-Driven Evolution of a Diagnostic Multiplex IgE-Test: Enhancing Accuracy and Efficacy in Allergy Diagnostics. International Journal of Molecular Sciences, 2025. 26(9): p. 4249.

[6] Matricardi, P.M., et al. Molecular allergy diagnosis enabling personalized medicine. J Allergy Clin Immunol, 2025. 156(3): p. 485-502.

[7] Hoffmann-Sommergruber, K., et al. Molecular Allergology User’s Guide 2.0. 2022.

[8] Petrova, S., et al. Structure And Biological Functions Of Milk Caseins. Russian Open Medical Journal, 2022. 11.

[9] Haidar, L., et al. Pollen–Food Allergy Syndrome: Allergens, Clinical Insights, Diagnostic and Therapeutic Challenges. Applied Sciences, 2025. 15(1): p. 66.

[10] Pomés, A., et al. Interfaces between allergen structure and diagnosis: know your epitopes. Curr Allergy Asthma Rep, 2015. 15(8): p. 506.

[11] Mills, C., et al. The role of processing and the food matrix in allergenicity of foods. http://dx.doi.org/10.1051/IUFoST:20061342, 2006.

[12] Paolucci, M., et al. Heat-treated egg allergens show lower basophil activation: A path toward safer oral immunotherapy. Pediatr Allergy Immunol, 2026. 37(1): p. e70275.

Dr hab. n. med. Katarzyna Plata-Nazar, Alergia u niemowlaka. Kiedy potrzebne jest mleko na receptę? (s. 27)

[1] Vandenplas Y. (red), An ESPGHAN Position Paper on the Diagnosis, Management, and Prevention of Cow’s Milk Allergy (2024). Journal of Pediatric Gastroenterology and Nutrition, 78, 386–413.
[2] Albrecht P. (red), Gastroenterologia dziecięca (2023), wyd II. Lublin, Wydawnictwo Czelej.
[3] Socha P., Lebensztejn D., Kamińska D. (red.), Gastroenterologia dziecięca (2024), wyd II. Warszawa, Standardy Medyczne.
[4] Jahnz-Różyk K., Kupczyk M., Gajewski P. (red.), Alergologia. Podręcznik specjalistyczny (2024). Kraków, Medycyna Praktyczna.
[5] Szajewska H., Horvath A. (red.), Żywienie i leczenie żywieniowe dzieci i młodzieży (2024), wyd. II. Kraków, Medycyna Praktyczna.
[6] Horvath A., Jarocka-Cyrta E., Nowak-Węgrzyn A., Błażowski Ł., Szajewska H., Cudowska B., Krauze A., Kurzawa R., Stróżyk A., Diagnostyka i leczenie alergii na białka mleka krowiego. Stanowisko Sekcji Alergii na Pokarmy Polskiego Towarzystwa Gastroenterologii, Hepatologii i Żywienia Dzieci (2021). Standardy Medyczne/Pediatria, 18, 342–362.

Diet. Alicja Wujkowska, Nieoczywiste źródła orzechów w diecie. Na co uważać? (s. 32)

[1] Anibarro B., Seoane F. J., Mugica M. V., Involvement of hidden allergens in food allergic reactions (2007). Journal of Investigational Allergology and Clinical Immunology, 17(3), 168–172.

[2] Steinman H. A., „Hidden” allergens in foods (1996). Journal of Allergy and Clinical Immunology, 98(2), 241–250.

[3] Parrinello G., Fontana D. E., Villalta D., An overview of hidden food allergens: need for change to the priority food allergen lists? (2025). European Annals of Allergy and Clinical Immunology, 57 (2), 51–67.

[4] Tomei L., Muraro A., Giovannini M., Barni S., Liccioli G., Paladini E., Mori F., Hidden and rare food allergens in pediatric age (2023). Nutrients, 15(6), 1386.

[5] Teuber S. S., Brown R. L., Haapanen L. D., Allergenicity of gourmet nut oils processed by different methods (1997). Journal of Allergy and Clinical Immunology, 99(4), 502–507.

[6] Michalak M., Kiełtyka–Dadasiewicz A., Nut oils and their dietetic and cosmetic significance: a review (2019). Journal of Oleo Science, 68(2), 111–120.

[7] Ryczaj K., Chojnowska–Wójtowicz M., Dumycz K., Feleszko W., Kulus M., Prevalence of major food allergens in skincare products for atopic dermatitis (2023). Advances in Dermatology and Allergology, 40(6), 762–765.

[8] Trimeche K., Lahouel I., Belhadjali H., Mohamed M., Zili J., Contact sensitization in pediatric population with atopic dermatitis: A setrospective Study of 80 patients (2022). Dermatitis, 33(6S1), S114–S118.

[9] Ramirez Jr D. A., Bahna S. L., Food hypersensitivity by inhalation (2009). Clinical and Molecular Allergy, 7(1), 4.

[10] Simonte S. J., Ma S., Mofidi S., Sicherer S. H., Relevance of casual contact with peanut butter in children with peanut allergy (2003). Journal of Allergy and Clinical Immunology, 112(1), 180–182.

[11] Niewczas–Dobrowolska M., Jakość i bezpieczeństwo żywności. Systemy–Postawy–Konsumenci (2020). Wydawnictwo Naukowe PTTŻ, Kraków, 23–107.

[12] Rozporządzenie Parlamentu Europejskiego i Rady (UE) nr 1169/2011 z dnia 25 października 2011 r. ws. przekazywania konsumentom informacji na temat żywności.

[13] Buchanan R., Dennis S., Gendel S., Acheson D., Assimon S. A., Beru N., Threshold Working Group., Approaches to establish thresholds for major food allergens and for gluten in food (2008). Journal of Food Protection, 71(5), 1043–1088.

[14] Puglisi G., Frieri M., Update on hidden food allergens and food labeling (2007). Allergy and Asthma Proceedings, 28(6), 634.

[15] https://www.foodallergy.org/living-food-allergies/food-allergy-essentials/common-allergens/tree-nut [Dostęp w dniu 27.07.2025]

[16] Kuźmiński A. i in., Tree nut allergy (2021). Advances in Dermatology and Allergology,  38(4), 358–363.

[17] Smeekens J., Bagley K., Kulis M. i in., Tree nut allergies: allergen homology, cross-reactivity, and implications for therapy (2018). Clinical&Experimental Allergy, 48, 762–772.

[18] Lyons S. A. i in., Walnut allergy across Europe: Distribution of allergen sensitization patterns and prediction of severity (2021). The Journal of Allergy and Clinical Immunology: In Practice, 9(1), 225–235.

Natalia Gajek, Soczyste, ale groźne. Alergia na brzoskwinie w pigułce (s. 36)

[1] Kulczyński B., Brzoskwinia: wartości odżywcze, właściwości i przeciwskazania, https://vitapedia.pl/brzoskwinia [dostęp: 6.07.23].

[2] Fernandez-Rivas M. Peach allergy: different clinical profiles across Europe. Clin Trans Allergy 2011; 1: 58.

[3] Zielińska J., Leśny M., Ukleja-Sokołowska N., Gawrońska-Ukleja E., Bartuzi Z.,  Alergia na brzoskwinie – obecny stan wiedzy, Alergia Astma Immunologia 2018, 23 (2): 67-72.

[4] Ciprandi G, De Amici M, Di Martino ML, et al. The impact of age on Pru p 3 IgE production in Italy. Asia Pac Allergy 2017; 7: 42-7.

[5] Ukleja-Sokołowska N., Zacniewski R., Gocki J., Żbikowska-Gotz M., Lis K., Sokołowski Ł., Bartuzi Z., Uczulenie na LTP czy anafilaksja zależna od posiłku wywołana wysiłkiem fizycznym?, Alergia Astma Immunologia 2017, 22 (4): 87-92.
[6] Rymarczyk B., Rogala B., Alergia pokarmowa, Alergie w POZ w: Alergologia – kompendium, Termedia, 2018.

[7] Rodriguez J, Crespo JF, Lper-Rubio A, et al. Clinical cross-reactivity among foods of the Rosaceae Family. J Allergy Clin Immunol 2000; 106: 183-9.

[8] Ukleja-Sokołowska N., Bartuzi M., Bartuzi Z., Jak przygotować podwójnie ślepą próbę prowokacji kontrolowaną placebo? – trudna sztuka zaślepiania pokarmów, Alergia Astma Immunologia 2021, 26 (4): 89-95.

[9] Emeryk A., Bartkowiak-Emeryk M., Diagnostyka alergologiczna, Choroby alergiczne w praktyce lekarza rodzinnego, 2019.

Aleksandra Lipiec, Szlachetna herbata i rzadka alergia. Co kryje się w matchy? (s. 38)

[1] Kajita N., Miyama S., Kinoshita K., Yoshida K., Narita M., Green tea-induced anaphylaxis: The first pediatric case report (2021). Allergology International, 70(4), 507–508.

[2] Mourelle R., Pineda F., Ojeda I. et al., Anaphylaxis Caused by Green Tea: A Case Report (2018). Journal of Investigational Allergology and Clinical Immunology, 28(5), 343–344.

[3] Shirai T., Sato A., Hara Y., Epigallocatechin Gallate The Major Causative Agent of Green Tea-Induced Asthma (1994). Chest,106(6), 1801–1805.

[4] Weiss D.J., Anderton Ch.R., Determination of catechins in matcha green tea by micellar electrokinetic chromatography (2003). Journal of Chromatography A, 1011(1–2), 173–180.

[5] Kochman J., Jakubczyk K., Antoniewicz J., Mruk H., Janda K., Health Benefits and Chemical Composition of Matcha Green Tea: A Review (2020). Molecules, 27;26(1), 85.

[6] Phuah Y. O., Chang S.K., Ng W. J., A review on matcha: Chemical composition, health benefits, with insights on its quality control by applying chemometrics and multi-omics (2023). Food Research International, 170, 113007.

Loratadyna Galena bez laktozy (s. 39)

[1] Salmun L.M., Gates D., Scharf M., Greiding L., Ramon F., Heithoff K., Loratadine versus cetirizine: assessment of somnolence and motivation during the workday (2000). Clinical Therapeutics, 22(5), 573–582.

[2] Charakterystyka Produktu Leczniczego Loratadyna Galena.

[3] Obwieszczenie Ministra Zdrowia z dnia 17 marca 2026 r. w sprawie wykazu refundowanych leków, środków spożywczych specjalnego przeznaczenia żywieniowego oraz wyrobów medycznych na 1 kwietnia 2026 r.

[4] Ulotka informacyjna Loratadyna Galena.

[5] Obwieszczenie Ministra Zdrowia z dnia 17 marca 2026 r. w sprawie wykazu refundowanych leków, środków spożywczych specjalnego przeznaczenia żywieniowego oraz wyrobów medycznych na 1 kwietnia 2026 r.

Prof. dr hab. n. med. Rafał Pawliczak, Terapia złożona w alergicznym nieżycie nosa (s. 40)

[1] Grzegorzewski, D., et al., Analysis of criteria for choosing drug treatment strategies in allergic rhinitis. Front Pharmacol, 2024. 15: p. 1340554.

[2] Sima, Y., et al., Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis. World Allergy Organ J, 2026. 19(3): p. 101341.

[3] Patel, P., A.M. Salapatek, and S.K. Tantry, Effect of olopatadine-mometasone combination nasal spray on seasonal allergic rhinitis symptoms in an environmental exposure chamber study. Ann Allergy Asthma Immunol, 2019. 122(2): p. 160-166 e1.

[4] Hampel, F.C., et al., Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis. Allergy Asthma Proc, 2019. 40(4): p. 261-272.

[5] Gross, G.N., et al., Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol, 2019. 122(6): p. 630-638 e3.

[6] Segall, N., et al., Long-term safety and efficacy of olopatadine-mometasone combination nasal spray in patients with perennial allergic rhinitis. Allergy Asthma Proc, 2019. 40(5): p. 301-310.

[7] Fifer, S., et al., Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia – An Observational Real-World Clinical Study. Patient Prefer Adherence, 2023. 17: p. 141-151.

Lek. Danuta Ostrowska-Reguła, Odczulanie na brzozę krok po kroku. Ile trwa, jak przebiega i kiedy zacząć? (s. 42)

[1] Fal A.M., Alergia, choroby alergiczne, astma (2011). Medycyna Praktyczna, Kraków.

[2] Jahnz-Różyk K., Kupczyk M., Gajewski P. i in., Alergologia. Podręcznik specjalistyczny (2024). Medycyna Praktyczna, Kraków.

[3] Kruszewski J., Kowalski M., Kulus M. i in., Standardy w alergologii (2019). Wydawnictwo Medyczne Termedia, Poznań.

Prof. dr hab. n. med Maciej Kupczyk, Ebastyna w codziennej praktyce klinicznej (s. 46)

[1] Kupczyk M. Ebastyna w terapii chorób alergicznych. Alergoprofil 2022, Vol. 18, Nr 1, 3-7, DOI: 10.24292/01.AP.181210222

[2] Evastix charakterystyka produktu leczniczego https://rejestrymedyczne.ezdrowie.gov.pl/api/rpl/medicinal-products/40404/characteristic

[3] Samoliński B, Krzych-Fałta E, Piekarska B et al. ARIA-2019 – zintegrowana opieka w alergicznym nieżycie nosa – Polska. Alergologia Polska – Polish Journal of Allergology. 2019; 6(4): 111-26.

[4] Hampel F, Howland S, Van Bavel J i wsp. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis. J Investig Allergol Clin Immunol. 2004;14(1):56-63.

[5] Ratner PH, Lim JC, Georges GC i wsp. Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg and placebo in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 2000; 105:1101-7.

[6] Gehanno P, Bernard-Oury C, Zeisser P. Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults. Ann Allergy Asthma Immunol 1996; 76:507-12.

[7] Bousquet J, Gaudano EM, Palma Carlos AG i wsp. A 12-week, placebo controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Allergy 1999; 54:562-568.

[8] Zuberbier T, Abdul Hameed Ansari Z, Abdul Latiff AH i wsp. The international guideline for the definition, classification, diagnosis and management of urticaria. Allergy, 2026; 0:1–51 https://doi.org/10.1111/all.70210

[9] Nowicki R, Grubska-Suchanek E, Jahnz-Różyk K i wsp. Pokrzywka. Interdyscyplinarne rekomendacje diagnostyczno-terapeutyczne Polskiego Towarzystwa Dermatologicznego i Polskiego Towarzystwa Alergologicznego. Alergologia Polska – Polish Journal of Allergology 2020;7(1):31-9

[10] Antonijoan RM, García-Gea C, Puntes M i wsp. A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults. Clin Drug Investig. 2007;27:453-61

[11] Goyal V, Gupta A, Gupta O i wsp. Comparative efficacy and safety of ebastine 20 mg, ebastine 10 mg and levocetirizine 5 mg in acute urticaria. J Clin Diagn Res. 2017;11:WC06-9

[12] Kwauchi H, Yanai K, Wang DY  i wsp. Antihistamines for allergic rhinitis treatment from the viewpoint of nonsedative properties  Int. J. Mol. Sci. 2019; 20(1): 213

Aleksandra Lipiec, Krajobraz wysokiego ryzyka. Alergia w mieście (s. 48)

[1] GUS. Ochrona zdrowia w gospodarstwach domowych 30.10.2024 r. w 2023 r. – wyniki wstępne (2024). Online: https://stat.gov.pl/download/gfx/portalinformacyjny/pl/defaultaktualnosci/5513/30/1/1/ochrona_zdrowia_w_gospodarstwach_domowych_w_2023_wyniki_wstepne.pdf

[2] GUS. Stan zdrowia ludności Polski w 2019 (2021). Online: https://stat.gov.pl/obszary-tematyczne/zdrowie/zdrowie/stan-zdrowia-ludnosci-polski-w-2019-r-,26,1.html

[3] Samoliński B. i in., Epidemiologia Chorób Alergicznych w Polsce (ECAP) (2014). Czasopismo Alergologia Polska – Polish Journal of Allergology, 1(1), 10–18.

[4] Samoliński B. i in., Częstość występowania alergii w Polsce – program ECAP (2007). Alergoprofil, 3(4), 26-28.

[5] Piotrowicz K., Myszkowska D., Zmiany klimatu i ich wpływ na sezony pyłkowe wybranych roślin alergennych w Polsce (2019). W: Kolendowicz L., Bednorz E., Tomczyk A.M. (red.), Zmienność klimatu Polski i Europy oraz jej cyrkulacyjne uwarunkowania. Bogucki – Wydawnictwo Naukowe, Poznań.

[6] Krzych-Fałta E., Samoliński B., Alergiczny nieżyt nosa  i astma oskrzelowa – jeden układ dwie choroby (2020). Alergia, 1, 33–38.

[7] Pałczyński C., Dudek W., Kręcisz B., Zmiany klimatu, miejska wyspa ciepła i choroby alergiczne (2012). Alergia, 4, 26–28.

[8] Pałczyński C., Kupryś-Lipińska I., Kuna P., Zmiany klimatyczne  a alergia i astma (2019). Alergia 3, 24–26.

[9] Majkowska-Wojciechowska B., Metody badań aerobiologicznych – postępy naukowe i technologiczne (2020). Alergia Astma Immunologia, 25(3), 141–153.

[10] Stawoska I. i in., Air pollution in the places of Betula pendula growth and development changes the physicochemical properties and the main allergen content of its pollen (2023). PLoS ONE, 18(1), e0279826.

[11] Rapiejko P., Kalendarz pylenia roślin (2011). Medycyna Praktyczna. Online: https://www.mp.pl/pacjent/alergie/chorobyalergiczne/alergeny/wziewne/62431,kalendarz-pylenia-roslin

Aleksandra Lipiec, Platan w każdym parku? Przed nami pyłkowy armagedon (s. 50)

[1] Zarzyński P., Tomusiak R., Platan Olbrzym, [w:] 90 drzew. Okazy niezwykłe, Centrum Informacyjne Lasów Państwowych.

[2] Detection of airborne allergen (Pla a 1) in relation to Platanus pollen in Córdoba, South Spain (2015). Annals of Agricultural and Environmental Medicine, 22(1), 96–101.

[3] Allergen Nomenclature. WHO/IUIS Allergen Nomenclature Sub-Committee. Financial contributions from IUIS, EAACI, and AAAAI. Online: https://allergen.org/

[4] Błażowski Ł., Gregorczyk-Maślanka K., Kurzawa R., Zespół alergii jamy ustnej (zespół pyłkowo-pokarmowy), anafilaksja i alergologia molekularna. Nowe endotypy, nowe horyzonty (2016). Alergologia Polska, 3, 137–143.

[5] Tsvetanova R., Allergenic potential of Platanus L. species in urban environment (2021). Acta Scientifica Naturalis, 8(3), 29–40.

[6] Enrique E. i in., Platanus acerifolia pollinosis and food allergy (2002). Allergy, 57(4), 351–356.

[7] Puc M. i in., Pyłek platana w powietrzu wybranych miast Polski w 2014 r. (2014). Alergoprofil, 10(3), 54–57.

[8] Rapiejko P., Alergeny pyłku platanu (2008). Alergoprofil, 4(2), 33–36.

Agnieszka Kalinowska, Bylica różne ma oblicza (s. 52)

[1] Rapiejko P.,  Alergeny pyłku roślin (2012).

[2] Kowalczyk S., Głos Syreneusza w sprawie wykorzystywania roślin w magii (2020).

[3] Udziela S., Rośliny w wierzeniach ludu krakowskiego (1931).

[4] Buczyłko K. , Molekuły alergenowe (2013–2019). Wydawnictwo Alergologiczne „Zdrowie”.

[5] Gruber P. i in., Role of the polypeptide backbone and post-translational modifications in cross-reactivity of Art v 1, the major mugwort pollen alergen (2009).

[6] Jura-Szołtys E., Rogala B., Immunoterapia w alergiach sezonowych (2016).

Aleksandra Lipiec, W maju pylą nie tylko trawy. Pyłki szczawiu pod lupą (s. 54)

[1] Weber R.W., Sheep sorrel (2004). Annals of Allergy, Asthma & Immunology, 93(2), A6.

[2] Wegiera M., Smolarz D.H., Właściwości lecznicze szczawi (Rumex. sp. L.) (2005). Postępy Fitoterapii 3–4, 98–102.

[3] Dąbrowska A., Ziarna pyłku szczawiu (Rumex L.) i babki (Plantago L.) w powietrzu dwóch dzielnic Lublina i Krasnegostawu /Pollen Grains of Rumex and Plantago in the Air of Two Districts of Lublin and Krasnystaw (2003). Annales Universitatis Mariae Curie-Skłodowska Lublin – Polonia, vol. XIII, sec. EEE, 349–354.

[4] OBAS. Serwis alergologiczny. Online: http://www.alergen.info.pl/ 

[5] Weryszko-Chmielewska E. i in., Analiza sezonów pyłkowych szczawiu w wybranych miastach Polski  w 2011 roku (2011). Alergoprofil, 7(4), 21–24.

[6] Korpelainen H., Pietiläinen M., Sorrel (Rumex acetosa L.): Not Only a Weed but a Promising Vegetable and Medicinal Plant (2020). The Botanical Review, 86(10).

[7] Kalemba-Drożdż M., Czy szczaw powoduje kamicę szczawianową? Przegląd czynników dietetycznych wpływających na ryzyko wystąpienia tej choroby (2020). Medycyna Ogólna i Nauki o Zdrowiu, 26(1), 29–34.

[8] Rapiejko P., Pyłek szczawiu. Online: https://www.odetchnijspokojnie.pl/pylek-szczawiu/

[9] Puc M., Characterisation of pollen allergens (2003). Annals of Agricultural and Environmental Medicine, 10, 143–149.

Sylwia Gałązka, Pyłki roślin. Czy sa się od nich uciec? (s. 56)

[1] Rapiejko P., Lipiec A., Monitoring pyłkowy w praktyce AD 2017, Alergia, 2017, 2; 17-19.

[2] Borycka, K., Kasprzyk, I., Hourly pattern of allergenic alder and birch pollen concentrations in the air: Spatial differentiation and the effect of meteorological conditions, Atmospheric Environment (2018).

[3] Gautier C, Charpin D. Environmental triggers and avoidance in the management of asthma. J Asthma Allergy. 2017; 10: 47–56.

[4] Takahashi Y., Takano K., Suzuki M., S Nagai, Yokosuka M., Takeshita T., Saito A., Yasueda H., Enomoto T., Two Routes for Pollen Entering Indoors: Ventilation and Clothes. J Investig Allergol Clin Immunol 2008; Vol. 18(5): 382-388.

[5] Baxi SN, Phipatanakul W. The Role of Allergen Exposure and Avoidance in Asthma. Adolesc Med State Art Rev. 2010 Apr; 21(1): 57–ix.

Ryaltris. Maksymalna kontrola objawów (s. 57)

[1] Ryaltris – Charakterystyka Produktu Leczniczego. Rejestr Produktów Leczniczych. Online: https://rejestry.ezdrowie.gov.pl/medicinal-products/43139/characteristic

[2] Kuna P., Kombinacja mometazonu z olopatadyną w leczeniu alergicznego nieżytu nosa – najnowsze wytyczne i wnioski z badania obserwacyjnego polskich pacjentów (2025). Terapia, Reprint z nr 4, 3–10.

[3] Patterlini V. , Guareschi F., D’Angelo D. et al., Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays (2024). Pharmaceutics, 16, 989.

[4] Emeryk A., Panas-Hołowacz K., Mometazon z olopatadyną w alergicznym nieżycie nosa (2025). Świat Medycyny i Farmacji, 3(282), 50–55.

[5] Meltzer E.O., Garadi R., LaForce C., Comparative study of sensory attributes of two antihistamine nasal sprays: Olopatadine 0.6% and azelastine 0.1% (2008). Allergy and Asthma Proceedings, 29, 659 –668.

Agnieszka Stańczak, Plastik na skórze. Czy poliester uczula? (s. 58)

[1] Brown A.E., Re K.A. Polyester fiber: From its invention to its present position (1971). Science, 173(3994), 254–258.

[2] Mubarak S. i in. Super-Hydrophobicity of Polyester Fabrics Driven by Surface Functionalization (2023). Polymers, 15(3), 5512. Online: https://pmc.ncbi.nlm.nih.gov/articles/PMC9957304/

[3] Mobolaji-Lawal M., Nedorost S., The Role of Textiles in Dermatitis: An Update (2015). Current Allergy and Asthma Reports, 15(4), 17.

[4] Coman G., Blattner C.M., Blickenstaff N.R., Andersen R., Maibach H.I. Textile allergic contact dermatitis: current status (2014). Reviews on Environmental Health, 29(3), 163–168.

[5] Malinauskiene L., Bruze M., Ryberg K., Zimerson E., Isaksson M. Contact allergy from disperse dyes in textiles – a review (2013). Contact Dermatitis, 68(2), 65–75.

[6] Lis K., Testy na alergię w pigułce (2022). Strefa Alergii. Online: https://strefaalergii.pl/abc-alergii/testy-na-alergie-w-pigulce/

Agnieszka Stańczak, Pod przykrywką. Alergia na cynk (s. 60)

[1] Kaur K., Gupta R., Saraf S.A., Saraf S.K., Zinc: The Metal of Life (2014). Comprehensive Reviews in Food Science and FoodSafety,13(4), 358–376.

[2] Chasapis C.T., Ntoupa P.A., Spiliopoulou C.A., Stefanidou M.E., Recent aspects of the effects of zinc on human health (2020). Archives of Toxicology, 94(5), 1443–1460.

[3] Cannas D., Loi E., Serra M., Firinu D., Valera P., Zavattari P., Relevance of Essential Trace Elements in Nutrition and Drinking Water for Human Health and Autoimmune Disease Risk (2020). Nutrients, 12(7), 2074. Online: https://www.mdpi.com/2072-6643/12/7/2074

[4] Yoshihisa Y., Shimizu T., Metal allergy and systemic contact dermatitis: an overview (2012). Dermatology Research and Practice, 749561. Online:  https://pmc.ncbi.nlm.nih.gov/articles/PMC3369403/

[5] Bratteland N.M.A., Ervik T.K., Alfonso J.H., Allergic contact dermatitis to zinc caused by silver ring splint: Exposure assessment with scanning electron microscope (2024). Contact Dermatitis, 91(4), 344–346. Online: https://onlinelibrary.wiley.com/doi/full/10.1111/cod.14598

[6] Nowak D., Gomułka K., Dziemieszonek P., Panaszek B., Systemowe kontaktowe zapalenie skóry (2016). Postępy Higieny i Medycyny Doświadczalnej, 70, 124–134. Online: https://phmd.hirszfeld.pl/wp-content/uploads/2023/07/1195845.pdf

[7] Sakai T., Hatano Y., Fujiwara S., Systemic Contact Dermatitis due to Zinc Successfully Treated with a Zinc-Restricted Diet: A Case Report (2013). Allergology International, 62(2), 265–267. Online: https://www.researchgate.net/publication/236276448_Systemic_Contact_Dermatitis_due_to_Zinc_Successfully_Treated_with_a_Zinc-Restricted_Diet_A_Case_Report

[8] Kalinowska A., Diagnozowanie alergii (2021). Strefa Alergii. Online: https://strefaalergii.pl/abc-alergii/diagnozowanie-alergii/

Barbara Bukowska, Anatomia nadwrażliwości. Co trzeba wiedzieć o uczuleniu na kontrast? (s. 62)

[1] Pasternak J.J., Williamson E.E., Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: a primer for the non-radiologist (2012). Mayo Clinic Proceedings, 87(4), 390–402.

[2] Baerlocher M.O., Asch M., Myers A., The use of contrast media (2010). Canadian Medical Association Journal, 182(7), 697.

[3] Andreucci M., Solomon R., Tasanarong A., Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention (2014). BioMed Research International, 2014, 741018.

[4] Namasivayam S., Kalra M.K., Torres W.E., et al., Adverse reactions to intravenous iodinated contrast media: a primer for radiologists (2006). Emergency Radiology, 12(5), 210–215.

[5] Nittner-Marszalska M., Bochenek G., Bodzenta-Łukaszyk A. et al., Nadwrażliwość na jodowe środki kontrastowe. Wytyczne Sekcji Nadwrażliwości na Leki Polskiego Towarzystwa Alergologicznego (2018). Alergologia Polska, 5(1), 16–25.

[6] van der Molen A.J., van de Ven A.A.J.M., Vega F. et al., Rare delayed hypersensitivity reactions to contrast media: Severe cutaneous adverse reactions (2025). European Journal of Radiology, 183, 111908.

[7] Kim M.H., Lee S.Y., Lee S.E., et al. Anaphylaxis to iodinated contrast media: clinical characteristics related with development of anaphylactic shock (2014). Public Library of Science One, 9(6), e100154.

[8] Nuñez-Borque E., Fernandez-Bravo S., Yuste-Montalvo A. et al., Pathophysiological, Cellular, and Molecular Events of the Vascular System in Anaphylaxis (2022). Frontiers in Immunology, 13, 836222.

[9] Thomsen H.S., Morcos S.K., ESUR. et al., ESUR guidelines on contrast media (2006). Abdominal Imaging, 31(2), 131–140.

[10] Schabelman E., Witting M., The relationship of radiocontrast, iodine, and seafood allergies: a medical myth exposed (2010). Journal of Emergency Medicine, 39(5), 701–707.

[11] Brockow K., Romano A., Aberer W. et al., Skin testing in patients with hypersensitivity reactions to iodinated contrast media – a European multicenter study (2009). Allergy, 64(2), 234–241.

[12] Kang H.R., Jeong J., Brockow K., Diagnosis and Prevention of Hypersensitivity Reactions to Iodinated Contrast Media (2022). Allergy, Asthma & Immunology Research, 14(4), 348-360.

[13] Wang C., Ramsey A., Lang D. et al., Management and Prevention of Hypersensitivity Reactions to Radiocontrast Media: A Consensus Statement From the American College of Radiology and the AAAAI (2025). The Journal of Allergy and Clinical Immunology: In Practice, S2213-2198(25)00191-6.

Maria Cabaj, Na styku mikrobiomu i alergii. Rola grzybów Malassezia w AZS (s. 65)

[1] Dramburg S, Hilger C, Santos AF et al. EAACI Molecular Allergology User’s Guide 2.0. Pediatr Allergy Immunol. 2023 Mar;34 Suppl 28:e13854. PMID: 37186333.

[2] Ianiri G, LeibundGut-Landmann S, Dawson TL Jr. Malassezia: A Commensal, Pathogen, and Mutualist of Human and Animal Skin. Annu Rev Microbiol. 2022 Sep 8;76:757-782. PMID: 36075093.

[3] Saunte DML, Gaitanis G, Hay RJ. Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment. Front Cell Infect Microbiol. 2020 Mar 20;10:112. PMID: 32266163.

[4] Kolb L, Ferrer-Bruker SJ. Atopic Dermatitis. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK448071/. Dostęp 19.02.2026.

[5] Thyssen JP, Halling AS, Schmid-Grendelmeier P et al. Comorbidities of atopic dermatitis-what does the evidence say? J Allergy Clin Immunol. 2023 May;151(5):1155-1162. Epub 2023 Jan 6. PMID: 36621338.

[6] Kiguchi T, Yamamoto-Hanada K, Saito-Abe M et al. Eczema phenotypes and IgE component sensitization in adolescents: A population-based birth cohort. Allergol Int. 2023 Jan;72(1):107-115. Epub 2022 Jul 1. PMID: 35781407.

[7] See Tow HX, Yew YW. Malassezia specific IgE in head and neck dermatitis of eczema: A systematic review & meta-analysis. Exp Dermatol. 2024 Jun;33(6):e15108. PMID: 38855891.

[8] Allergen Nomenclature. WHO/IUIS Allergen Nomenclature Sub-Committee. https://allergen.org/ , Dostęp 19.02.2026.

[9] Corzo Leon DE, Scheynius A, MacCallum DM, Munro CA. Malassezia sympodialis Mala s 1 allergen is a potential KELCH protein that cross reacts with human skin. FEMS Yeast Res. 2023 Jan 4;23:foad028. PMID: 37188635; PMCID: PMC10281499.

[10] De Bruyn Carlier T, Badloe FMS, Ring J et al. Autoreactive T cells and their role in atopic dermatitis. J Autoimmun. 2021 Jun;120:102634. Epub 2021 Apr 20. PMID: 33892348.

[11] Celakovska J, Vankova R, Bukac J et al. Atopic Dermatitis and Sensitisation to Molecular Components of Alternaria, Cladosporium, Penicillium, Aspergillus, and Malassezia-Results of Allergy Explorer ALEX 2. J Fungi (Basel). 2021 Mar 4;7(3):183. PMID: 33806376.

[12] Scala E, Madonna S, Abeni D, Cecchi L et al. A microarray-based IgE-molecular mimicry index (IgE-MMI): A biomarker for disease severity, clinical phenotypes, and therapeutic response in atopic dermatitis? Allergy. 2024 Dec;79(12):3415-3429. Epub 2024 Nov 4. PMID: 39495073.

[13] Litus, Olexandr et al. Sensitization to Malassezia Sympodialis is Associated with Low Efficacy of Local Anti-inflammatory Therapy in Patients with Contact Dermatitis. Journal of Allergy and Clinical Immunology, Volume 149, Issue 2.

[14] Chong AC, Navarro-Triviño FJ, Su M, Park CO. Fungal Head and Neck Dermatitis: Current Understanding and Management. Clin Rev Allergy Immunol. 2024 Jun;66(3):363-375. Epub 2024 Jul 20. PMID: 39031274.

[15] Wollenberg A, Barbarot S, Bieber T et al.; European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS). Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018 Jun;32(6):850-878. PMID: 29878606.

[16] Bangert C, Alkon N, Chennareddy S et al. Dupilumab-associated head and neck dermatitis shows a pronounced type 22 immune signature mediated by oligoclonally expanded T cells. Nat Commun. 2024 Apr 2;15(1):2839. PMID: 38565563.

[17] Kozera E, Stewart T, Gill K et al. Dupilumab-associated head and neck dermatitis is associated with elevated pretreatment serum Malassezia-specific IgE: a multicentre, prospective cohort study. Br J Dermatol. 2022 Jun;186(6):1050-1052. Epub 2022 Apr 19. PMID: 35041759.

Prof. dr hab. n med. Krzysztof Buczyłko, Gronkowiec i alergia. Duet, który komplikuje leczenie (s. 68)

[1] Suhrkamp I., Fonfara M., Magdalena M. et al., CD4+ polarized Th2 T cells increase Staphylococcus aureus growth in 3D skin model (2025). Clinical and experimental allergy, 55 (5), 443–445.

[2] Krysko O., Teufelberger A., Van Nevel S. et al., Protease/antiprotease network in allergy: the role of Staphylococcus aureus protease proteins (2019). Allergy, 74(11), 2077–2086.

[3] Hülpüsch K., Tremmel K., Hammel G., Abundance of Staphylococcus aureus dependent on skin pH as a predictor of increased severity of atopic dermatitis (2020). Allergy (Copenhagen), 75(11), 2888–2898.

[4] Badolati I., Heiden M., Brodin D. et al., Staphylococcus aureus-derived factors promote human Th9 cell polarization and enhance a transcriptional program associated with allergic inflammation (2023). European Journal of Immunology, 53 (3), 2250083.

[5] Hartmann J., Moitinho-Silva L., Sander N. et al., Treatment with dupilumab, but not cyclosporine, shifts the microbiome towards healthy skin flora in patients with moderate to severe atopic dermatitis (2023). Allergy, 78(8), 2290–2300.

Dr n. med. Iwona Poziomkowska-Gęsicka, Przyczyna nieznana. Anafilaksja idiopatyczna (s. 70)

[1] Ring J, Brockow K, Behrendt H. History and classification of anaphylaxis. Novartis Found Symp. 2004;257:6-16; discussion 16-24, 45-50, 276-85. PMID: 15025389.

[2] Turner PJ, Worm M, Ansotegui IJ, El-Gamal Y et al. Time to revisit the definition and clinical criteria for anaphylaxis? World Allergy Organ J. 2019;12(10):100066. Published 2019 Oct 31.

[3] Tanno LK, Bierrenbach AL, Simons FER, Cardona V et al. Critical view of anaphylaxis epidemiology: open questions and new perspectives. Allergy Asthma Clin Immunol. 2018;14:12. Published 2018 Apr 4.

[4] Jimenez-Rodriguez TW, Garcia-Neuer M, Alenazy LA , Castells M. Anaphylaxis in the 21-st century: phenotypes, endotypes, and biomarkers. J Asthma Allergy. 2018;11:121-142.

[5] Sampson HA, Munoz‑Furlong A, Campbell RL, Adkinson NF Jr, et al. Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol. 2006;117:391–397

[6] Simons FER, Ardusso LR, Bilò MB, Cardona V, et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J. 2014;30(7):9.

[7] Muraro A, Roberts G, Worm M, Bilo MB, et al. on behalf of EAACI Food Allergy and Anaphylaxis Guidelines Group. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014.69:1026-45

[8] Worm M, Moneret-Vautrin DA, Scherer K, et al. First European data from the network of severe allergic reactions (NORA). Allergy. 2014; 67(10): 1397-1404

[9] Gonzalez-Estrada A, Silvers SK, Klein A, et al. Epidemiology of anaphylaxis at a tertiary care center: A report of 730 cases. Ann Allergy Asthma Immunol. 2017; 118(1): 80-85.

[10] Heaps A, Carter S, Selwood C, Moody M, et al. The utility of the ISAC allergen array in the investigation of idiopathic anaphylaxis. Clin Exp Immunol. 2014;177:483–490

[11] Krishna MT, Worm M, Bilo MB. Editorial: Anaphylaxis – A Distinct Immunological Syndrome, but How Much Do We Really Understand? Front Immunol. 2019;10:2943.

[12] Sievers S, Rawel HM, Ringel KP, Niggemann B et al. Wheat protein recognition pattern in tolerant and allergic children. Pediatr Allergy Immunol. 2016 Mar;27(2):147-55.

[13] Ricci G, Andreozzi L, Cipriani F, Giannetti A et al. Wheat Allergy in Children: A Comprehensive Update. Medicina (Kaunas). 2019 Jul 23;55(7):400. doi: 10.3390/medicina55070400. PMID: 31340608; PMCID: PMC6681225.

[14] Scherf KA, Brockow K, Biedermann T, Koehler P et al. Wheat-dependent exercise-induced anaphylaxis. Clin Exp Allergy. 2016 Jan;46(1):10-20.

[15] Hofmann SC, Fischer J, Eriksson C, Bengtsson Gref O et al. IgE detection to α/β/γ-gliadin and its clinical relevance in wheat-dependent exercise-induced anaphylaxis. Allergy. 2012 Nov;67(11):1457-1460.

[16] Poziomkowska-Gęsicka I. Idiopathic Anaphylaxis? Analysis of Data from the Anaphylaxis Registry for West Pomerania Province, Poland. Int J Environ Res Public Health. 2022 Dec 13;19(24):16716.

[17] Christensen MJ, Eller E, Mortz CG, Brockow K wt al. Wheat-Dependent Cofactor-Augmented Anaphylaxis: A Prospective Study of Exercise, Aspirin, and Alcohol Efficacy as Cofactors. J Allergy Clin Immunol Pract. 2019 Jan;7(1):114-121

[18] Brockow K, Kneissl D, Valentini L, Zelger O et al. Using a gluten oral food challenge protocol to improve diagnosis of wheat-dependent exercise-induced anaphylaxis. J Allergy Clin Immunol. 2015 Apr;135(4):977-984.

[19] Scherf KA, Lindenau AC, Valentini L, Collado MC et al. Cofactors of wheat-dependent exercise-induced anaphylaxis do not increase highly individual gliadin absorption in healthy volunteers. Clin Transl Allergy. 2019;9:19. Published 2019 Mar 25.

[20] Hompes S, Dölle S, Grünhagen J, Grabenhenrich L, et al. Elicitors and co-factors in food-induced anaphylaxis in adults. Clin Transl Allergy. 2013;3(1):38. Published 2013 Nov 21.

[21] Aihara M, Miyazawa M, Osuna H, Tsubaki K et al. Food-dependent exercise-induced anaphylaxis: influence of concurrent aspirin administration on skin testing and provocation. Br J Dermatol. 2002;146(3):466–472.

[22] Pascal M, Muñoz-Cano R, Reina Z, et al. Lipid transfer protein syndrome: clinical pattern, cofactor effect and profile of molecular sensitization to plant-foods and pollens. Clin Exp Allergy 2012; 42:1529-1539.

[23] Sancho AI, Foxall R, Rigby NM, Browne T et al. Maturity and storage influence on the apple (Malus domestica) allergen Mal d 3, a nonspecific lipid transfer protein. J Agric Food Chem. 2006 Jul 12;54(14):5098-5104.

[24] Asero R, Mistrello G, Roncarolo D, Amato S. Detection of some safe plant-derived foods for LTP-allergic patients. Int Arch Allergy Immunol 2007; 144: 57-63.

[25] Hilger C, Fischer J, Wölbing F, Biedermann T (2019): Role and mechanism of galactose-alpha-1,3-galactose in the elicitation of delayed anaphylactic reactions to red meat. Curr Allergy Asthma Rep 19: 3.

[26] Caponetto P, Fischer J, Biedermann T. Gelatin-containing sweets can elicit anaphylaxis in a patient with sensitization to galactose-a-1,3-galactose. J Allergy Clin Immunol Pract. 2013;1:302–303

[27] Commins SP, Satinover SM, Hosen J, Mozena J et al. Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose. J Allergy Clin Immunol. 2009 Feb;123(2):426-433.

[28] Pattanaik D, Lieberman P, Lieberman J, Pongdee T et al The changing face of anaphylaxis in adults and adolescents Ann Allergy Asthma Immunol., 121 (2018), pp. 594-597.

[29] Nurmatov UB, Rhatigan E, Simons FE, Sheikh A. H2-antihistamines for the treatment of anaphylaxis with and without shock: a systematic review. Ann Allergy Asthma Immunol 2014; 112: 126– 131.

Lek. Klaudia Fabijaniak, Kolagen rybi w teorii i praktyce. Od nierealnych obietnic po reakcje niepożądane (s. 78)

[1] Viscomi B., Muniz M., Sattler S., Managing Menopausal Skin Changes: A Narrative Review of Skin Quality Changes, Their Aesthetic Impact, and the Actual Role of Hormone Replacement Therapy in Improvement (2025). Journal of Cosmetic Dermatology, 24(4), e70393.

[2] Wang H.A., Review of the Effects of Collagen Treatment in Clinical Studies (2021). Polymers (Basel), 13(22), 3868.

[3] Choi FD, Sung CT, Juhasz ML, Mesinkovsk NA. Oral Collagen Supplementation: A Systematic Review of Dermatological Applications (2019). Journal of Drugs in Dermatology, 18(1), 9–16.

[4] Silva T.H., Moreira-Silva J., Marques A.L. et al., Marine origin collagens and its potential applications (2014). Marine Drugs, 12(12), 5881–5901.

[5] de Miranda R.B., Weimer P., Rossi R.C., Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis (2021). International Journal of Dermatology, 60(12), 1449–1461.
[6] Myung S.-K., Park Y., Effects of Collagen Supplements on Skin Aging: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2025). The American Journal of Medicine, 138(9), 1264–1277.

[7] Kobayashi Y., Akiyama H., Huge J. et al., Fish collagen is an important panallergen in the Japanese population (2016). Allergy, 71(5), 720–723.

[8] Ueno R., Takaoka Y., Shimojo N. et al., A case of pediatric anaphylaxis caused by gummy tablets containing fish collagen (2020). Asia Pacific Allergy, 10(4), e35.

[9] Kato K., Inoue E., An anaphylactic reaction after simultaneous injection of hyaluronic acid fillers and human collagen (2022). Journal of Cosmetic and Laser Therapy, 24(1–5), 60–62.

[10] Stapel S.O., Asero R., Ballmer-Weber B.K. et al., EAACI Task Force. Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report (2008). Allergy, 63(7), 793–796.
[11] Sharp M.F., Lopata A.L., Fish allergy: in review (2014). Clinical Reviews in Allergy & Immunology, 46(3), 258–271.

Dr hab. n. med. Emilia Majsiak, Spirulina – przeciwalergiczna czy alergizująca? (s. 80)

[1] Gromek W. et al., Spirulina (Arthrospira platensis): Antiallergic Agent or Hidden Allergen? A Literature Review (2004). Foods, 13(7).

[2] Hassoun A. et al., Consumer acceptance of new food trends resulting from the fourth industrial revolution technologies: A narrative review of literature and future perspectives (2022). Frontiers in Nutrition, 9.

[3] Yang H.-N. et al., Spirulina platensis inhibits anaphylactic reaction (1997). Life Sciences, 61(13), 1237–1244.

[4] Dillon J.C. et al., Nutritional Value of the Alga Spirulina (1995). Plants in Human Nutrition (ed. A.P. Simopoulos).

[5] Karkos, P.D. et al., Spirulina in Clinical Practice: Evidence-Based Human Applications (2011). Evidence-Based Complementary and Alternative Medicine, 1, 531053.

[6] Masojídek J.G., Torzillo, Mass Cultivation of Freshwater Microalgae (2014). Reference Module in Earth Systems and Environmental Sciences, Elsevier.

[7] Kay R.A., Barton L.L., Microalgae as food and supplement (1991). Critical Reviews in Food Science and Nutrition, 30(6), 555–573.

[8] Hashemian M. et al., Chapter 20 – Production of Microalgae-Derived High-Protein Biomass to Enhance Food for Animal Feedstock and Human Consumption (2019). Advanced Bioprocessing for Alternative Fuels, Biobased Chemicals, and Bioproducts (ed. M. Hosseini). Woodhead Publishing, 393–405.

[9] Kumar A. et al., Development of high Protein Nutrition Bar Enriched with Spirulina Plantensis for Undernourished Children (2018). Current Research in Nutrition and Food Science Journal, 6, 835–844.

[10] Niccolai A. et al., Development of new microalgae-based sourdough “crostini”: functional effects of Arthrospira platensis (spirulina) addition (2019). Scientific Reports, 9(1), 19433.

[11] Koh E.-J. et al., Spirulina maxima Extract Ameliorates Learning and Memory Impairments via Inhibiting GSK-3β Phosphorylation Induced by Intracerebroventricular Injection of Amyloid-β 1–42 in Mice (2017). International Journal of Molecular Sciences, 18(11), 2401.

[12] Serban M.-C. et al., A systematic review and meta-analysis of the impact of Spirulina supplementation on plasma lipid concentrations (2016). Clinical Nutrition, 35(4), 842–851.

[13] Yang L. et al., A network pharmacology and molecular docking approach to reveal the mechanism of Chaihu Anxin Capsule in depression (2023). Front Endocrinol (Lausanne), 14, 1256045.

[14] Yang H.N. et al., Spirulina platensis inhibits anaphylactic reaction (1997). Life Science, 61(13), 1237–1244.

[15] Hayashi O. et al., Class Specific Influence of Dietary Spirulina platensis on Antibody Production in Mice (1998). Journal of Nutritional Science and Vitaminology, 44(6), 841–851.

[16] Chen L.L. et al., [Experimental study of spirulina platensis in treating allergic rhinitis in rats] (2005). Zhong Nan Da Xue Xue Bao Yi Xue Ban, 30(1), 96–98.

[17] Mao T.K. et al., Effects of a Spirulina-based dietary supplement on cytokine production from allergic rhinitis patients (2005). Journal of Medicinal Food , 8(1), 27–30.

[18] Cingi C. et al., The effects of spirulina on allergic rhinitis (2008). European Archives of Oto-Rhino-Laryngology , 265(10), 1219–1223.

[19] Nourollahian M. et al., Clinical comparison of the efficacy of spirulina platensis and cetirizine for treatment of allergic rhinitis (2020). Acta Otorhinolaryngologica Italica, 40(3), 224–229.

[20] Petrus M. et al., First case report of anaphylaxis to spirulin: identification of phycocyanin as responsible allergen (2010). Allergy, 65(7), 924–925.

[21] Le T.-M. et al., Anaphylaxis to Spirulina confirmed by skin prick test with ingredients of Spirulina tablets (2014). Food and Chemical Toxicology, 74, 309–310.

[22] Pimblett P., Spirulina allergy: a case history of two patients (2020). World Allergy Organization Journal, 13(8), 100149.

[23] Pescosolido E. et al., Delayed IgE–mediated hypersensitivity to Arthrospira platensis (spirulina) (2022). Annals of Allergy, Asthma & Immunology, 129(4), 522 –524.

[24] Bianco M. et al., A new paradigm to search for allergenic proteins in novel foods by integrating proteomics analysis and in silico sequence homology prediction: Focus on spirulina and chlorella microalgae (2022). Talanta, 240, 123188.

[25] Vo T.-S. et al., Chapter 19 – Nutritional and Pharmaceutical Properties of Microalgal Spirulina, in Handbook of Marine Microalgae (ed. S.-K. Kim) (2015). Academic Press: Boston, 299–308.

[26] Grover P. et al., C-Phycocyanin-a novel protein from Spirulina platensis – In vivo toxicity, antioxidant and immunomodulatory studies (2021). Saudi Journal of Biological Sciences,  28(3), 1853–1859.

Diet. Marcelina Bartuzi-Lepczyńska, Mity o alergii pokarmowej u dzieci (s. 82)

MIT 1

[1] Sicherer S.H., Wood R.A., Vickery B.P. et al., The natural history of peanut allergy (2014). The Journal of Allergy and Clinical Immunology: In Practice, 2(1), 65–71.

[2] Fleischer D.M., Conover-Walker M.K., Matsui E.C., Wood R.A., The natural history of tree nut allergy (2005). Journal of Allergy and Clinical Immunology, 116(5), 1087–1093.

[3] Savage J.H., Matsui E.C., Skripak J.M., Wood R.A., The natural history of seafood allergy (2016). Journal of Allergy and Clinical Immunology, 137(1), 261–267.

[4] Turner P.J., Gowland M.H., Sharma V. et al., Increase in sesame allergy presentations since 1990 (2016). Journal of Allergy and Clinical Immunology, 138(5), 1368–1371.

[5] Wood R.A., Sicherer S.H., Vickery B.P. et al., The natural history of milk allergy in an observational cohort (2013). Journal of Allergy and Clinical Immunology, 131(3), 805–812.

[6] Du Toit G., Roberts G., Sayre P.H. et al., Randomized trial of peanut consumption in infants at risk for peanut allergy (2015). The New England Journal of Medicine, 372(9), 803–813.

[7] Bartha I., Almulhem N., Santos A.F., Feast for thought: A comprehensive review of food allergy 2021–2023 (2024). Journal of Allergy and Clinical Immunology, 153(3), 576–594.

[8] Nocerino R., Aquilone G., Stea S. et al., The Burden of Cow’s Milk Protein Allergy in the Pediatric Age: A Systematic Review of Costs and Challenges (2025). Healthcare (Basel), 13(8), 888.

MIT 2

[1] Logan K., Bahnson H.T., Ylescupidez A. et al., Early introduction of peanut reduces peanut allergy across risk groups in pooled and causal inference analyses (2023). Allergy, 78(5), 1307–1318.

[2] Lee E.C.K., Trogen B., Brady K., Ford L.S., Wang J., The Natural History and Risk Factors for the Development of Food Allergies in Children and Adults (2024). Current Allergy and Asthma Reports, 24(3), 121–131.

[3] Gallagher A., Delgado Mainar P., Cronin C. et al., Managing egg allergy: A systematic review of traditional allergen avoidance methods and emerging graded exposure strategies (2025). Pediatric Allergy and Immunology, 36(4), e70075.

[4] Sicherer S.H., Sampson H.A., Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment (2018). Journal of Allergy and Clinical Immunology, 141(1), 41–58.

[5] Strachan D.P., Hay fever, hygiene, and household size (1989). British Medical Journal, 299(6710), 1259–1260.

[6] Prescott S.L., Pawankar R., Allen K.J. et al., A global survey of changing patterns of food allergy burden in children (2013). World Allergy Organization Journal, 6(1), 21.

 

MIT 3

[1] American Academy of Pediatrics. Committee on Nutrition, Hypoallergenic infant formulas (2000). Pediatrics, 106(2), 346–349.

[2] Lack G., Fox D., Northstone K., Golding J., Factors associated with the development of peanut allergy in childhood (2003). The New England Journal of Medicine, 348(11), 977–985.

[3] Du Toit G., Roberts G., Sayre P.H. et al., Randomized trial of peanut consumption in infants at risk for peanut allergy (2015). The New England Journal of Medicine, 372(9), 803–13.

[4] Ierodiakonou D., Garcia-Larsen V., Logan A. et al., Timing of allergenic food introduction to the infant diet and risk of allergic or autoimmune disease: a systematic review and meta-analysis (2016). Journal of the American Medical Association, 316(11), 1181–1192.

[5] Perkin M.R., Logan K., Tseng A. et al., Randomized trial of introduction of allergenic foods in breast-fed infants (2016). The New England Journal of Medicine, 374(18), 1733–1743.

[6] Togias A., Cooper S.F., Acebal M.L. et al., Addendum guidelines for the prevention of peanut allergy in the United States: report of the NIAID-sponsored expert panel (2017). Annals of Allergy, Asthma & Immunology, 118(2), 166–173.

[7] Australasian Society of Clinical Immunology and Allergy (ASCIA) Guideline. Infant feeding and allergy prevention (2020).

[8] Feeney M., Du Toit G., Roberts G. et al., Impact of peanut consumption from infancy on the risk of allergic disease in the LEAP-Trio study: 12-year follow-up of the LEAP randomized trial (2024). Journal of Allergy and Clinical Immunology, 153(1), 204–212.

[9] Koletzko S., Niggemann B., Arato A. et al. Diagnostic approach and management of cow’s-milk protein allergy in infants and children: ESPGHAN GI Committee practical guidelines (2012). The Journal of Pediatric Gastroenterology and Nutrition, 55(2), 221–229.

[10] Sicherer S.H., Sampson H.A., Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management (2018). Journal of Allergy and Clinical Immunology, 141(1), 41–58.

[11] Muraro A., Werfel T., Beyer K. et al., EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy (2014). Allergy, 69(8), 1008–1025.

Może Cię zainteresować

Bibliografia
Magazyn 2025/2 (9) – Lekarz
Redakcja Strefy Alergii 24 marca 2025
Bibliografia
Magazyn 2026/1 (10) – Pacjent
28 kwietnia 2026
Bibliografia
Magazyn 2025/2 (9) – Pacjent
Redakcja Strefy Alergii 8 grudnia 2025